Volume 24, Issue 44 pp. 11245-11254
Concept

Efficiently Photocontrollable or Not? Biological Activity of Photoisomerizable Diarylethenes

Prof. Igor V. Komarov

Corresponding Author

Prof. Igor V. Komarov

Taras Shevchenko National University of Kyiv, vul. Volodymyrska 60, 01601 Kyiv, Ukraine

Lumobiotics GmbH, Auer Str. 2, 76227 Karlsruhe, Germany

Search for more papers by this author
Dr. Sergii Afonin

Dr. Sergii Afonin

Institute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology, POB 3640, 76021 Karlsruhe, Germany

Search for more papers by this author
Dr. Oleg Babii

Dr. Oleg Babii

Institute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology, POB 3640, 76021 Karlsruhe, Germany

Search for more papers by this author
Tim Schober

Tim Schober

Institute of Organic Chemistry (IOC), Karlsruhe Institute of Technology, Fritz-Haber-Weg 6, 76131 Karlsruhe, Germany

Search for more papers by this author
Prof. Anne S. Ulrich

Corresponding Author

Prof. Anne S. Ulrich

Institute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology, POB 3640, 76021 Karlsruhe, Germany

Institute of Organic Chemistry (IOC), Karlsruhe Institute of Technology, Fritz-Haber-Weg 6, 76131 Karlsruhe, Germany

Search for more papers by this author
First published: 06 April 2018
Citations: 39

Graphical Abstract

Drugs for photopharmacology: The development of diarylethene-based biologically active molecules is critically analysed. This concept article suggests design principles that should be accounted for in the construction of efficient photocontrollable molecules containing diarylethene-based molecular switches.

Abstract

Diarylethene derivatives, the biological activity of which can be reversibly changed by irradiation with light of different wavelengths, have shown promise as scientific tools and as candidates for photocontrollable drugs. However, examples demonstrating efficient photocontrol of their biological activity are still relatively rare. This concept article discusses the possible reasons for this situation and presents a critical analysis of existing data and hypotheses in this field, in order to extract the design principles enabling the construction of efficient photocontrollable diarylethene-based molecules. Papers addressing biologically relevant interactions between diarylethenes and biomolecules are analyzed; however, in most published cases, the efficiency of photocontrol in living systems remains to be demonstrated. We hope that this article will encourage further discussion of design principles, primarily among pharmacologists, synthetic and medicinal chemists.

Conflict of interest

I.V.K., S.A., O.B. and A.S.U. are inventors on the issued patent family: “Peptidomimetics possessing photocontrolled biological activity” (WO201412719 (A1), EP2958934 (B1), US9481712 (B2), UA113685 (C2)).